We did not incorporate other potentially crucial prognostic factors, such as systemic inflammatory biomarkers (e.g., high-sensitivity C-reactive protein), detailed history of medication use (in particular, the dosage and adherence to statin therapy), or prior history of stroke or transient ischemic attack. The gene discussed is CRP; the disease is stroke disorder.